Stay updated on Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.

Latest updates to the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page
- Check3 days agoChange DetectedThe study record page displays a 403 Forbidden message with a Home link. The site revision changed from v3.7.2 to v3.8.0.SummaryDifference0.6%

- Check10 days agoChange DetectedA banner announces NIH website updates and says some content may use “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference1%

- Check17 days agoChange DetectedThe footer revision number changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.SummaryDifference0.3%

- Check24 days agoChange DetectedThe ClinicalTrials.gov footer revision updated from v3.7.0 to v3.7.1 while the page continued to show a 403 error.SummaryDifference0.2%

- Check45 days agoChange DetectedThe page now shows a 403 Forbidden error, and the expected study content has been removed from view. The header and footer remain, but the core NCT04065555 study details and related navigation are no longer accessible on this page.SummaryDifference19%

- Check67 days agoChange DetectedRevision label on the page updated to v3.6.6, replacing the previous v3.6.5. This indicates a new version of the page was deployed, with no changes to the study content or data.SummaryDifference0.1%

Stay in the know with updates to Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.